|
Showing 1 - 2 of
2 matches in All Departments
In the last decade, there has been a remarkable explosion of
knowledge in hematologic cancer from basic molecular biology and
pathology to clinical therapy. This has led to many new advance and
insights in the understanding of pathobiology of malignant
hematology. New knowledge of disease molecular pathology,
cytogenetic, epigenetic and genomic alterations have provided new
strategies to attack and eradicate tumor cells at molecular level
and significantly impacted our current therapeutics for
hematological malignancies. The recent and ongoing rapid expansion
of knowledge in this area has become extensive, dynamic and diffuse
over the literature and research publications. This has led to the
need to capture and compile the new and current information about
hematologic cancer with special emphasis on translation from
molecular pathobiology to targeted therapeutics. In this book
experts from around the world share their thoughts and knowledge
about the pathobiology of hematologic cancer, as well as their view
on current treatment approaches and future development in these
malignant hematologic diseases. This book is well suited for
hematology residents, fellows and hematology-oncology physicians,
hematopathologist as well as basic research scientist in the area
of hematologic malignancies.
In the last decade, there has been a remarkable explosion of
knowledge in hematologic cancer from basic molecular biology and
pathology to clinical therapy. This has led to many new advance and
insights in the understanding of pathobiology of malignant
hematology. New knowledge of disease molecular pathology,
cytogenetic, epigenetic and genomic alterations have provided new
strategies to attack and eradicate tumor cells at molecular level
and significantly impacted our current therapeutics for
hematological malignancies. The recent and ongoing rapid expansion
of knowledge in this area has become extensive, dynamic and diffuse
over the literature and research publications. This has led to the
need to capture and compile the new and current information about
hematologic cancer with special emphasis on translation from
molecular pathobiology to targeted therapeutics. In this book
experts from around the world share their thoughts and knowledge
about the pathobiology of hematologic cancer, as well as their view
on current treatment approaches and future development in these
malignant hematologic diseases. This book is well suited for
hematology residents, fellows and hematology-oncology physicians,
hematopathologist as well as basic research scientist in the area
of hematologic malignancies.
|
You may like...
Loot
Nadine Gordimer
Paperback
(2)
R398
R330
Discovery Miles 3 300
Loot
Nadine Gordimer
Paperback
(2)
R398
R330
Discovery Miles 3 300
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.